Works matching DE "HER2 protein"

Results: 1260

Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.

Published in:

Modern Pathology, 2004, v. 17, n. 8, p. 895, doi. 10.1038/modpathol.3800137

By:

Ooi, Akishi;
Takehana, Takuo;
Xiaoling Li;
Suzuki, Shioto;
Kunitomo, Kazuyoshi;
Iino, Hiroshi;
Fujii, Hideki;
Takeda, Yasuhisa;
Dobashi, Yoh

Publication type:

Article

Her-2 expression in cutaneous eccrine and apocrine neoplasms.

Published in:

2004

By:

Hiatt, Kim M.;
Pillow, Jessica L.;
Smoller, Bruce R.

Publication type:

journal article

Expression of HER2 and C-KIT in Nasopharyngeal Carcinoma: Implications for a New Therapeutic Approach.

Published in:

Modern Pathology, 2003, v. 16, n. 10, p. 1035, doi. 10.1097/01.MP.0000089778.48167.91

By:

Bar-Sela, G.;
Kuten, A.;
Ben-Eliezer, S.;
Gov-Ari, E.;
Ben-Izhak, O.

Publication type:

Article

Correction: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer.

Published in:

2016

By:

Gijsen, Merel;
King, Peter;
Perera, Tim;
Parker, Peter J.;
Harris, Adrian L.;
Larijani, Banafshé;
Kong, Anthony

Publication type:

Correction Notice

Risk factors for HR- and HER2-defined breast cancer in Slovenian postmenopausal women.

Published in:

Climacteric, 2012, v. 15, n. 1, p. 68, doi. 10.3109/13697137.2011.609286

By:

Cerne, J-Z.;
Ferk, P.;
Frkovic-Grazio, S.;
Leskosek, B.;
Gersak, K.

Publication type:

Article

Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy.

Published in:

Biotechnology Letters, 2015, v. 37, n. 7, p. 1347, doi. 10.1007/s10529-015-1804-6

By:

Cao, Xiaodan;
Yu, Haijun;
Chen, Chao;
Wei, Jia;
Wang, Ping

Publication type:

Article

Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

Published in:

World Journal of Urology, 2015, v. 33, n. 12, p. 1951, doi. 10.1007/s00345-015-1557-9

By:

Ding, Weihong;
Tong, Shijun;
Gou, Yuancheng;
Sun, Chuanyu;
Wang, Hong;
Chen, Zhongqing;
Tan, Jun;
Xu, Ke;
Xia, Guowei;
Ding, Qiang

Publication type:

Article

Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2005, v. 371, n. 2, p. 141, doi. 10.1007/s00210-004-1016-4

By:

Abuharbeid, Shaker;
Apel, Jürgen;
Zugmaier, Gerhard;
Knabbe, Cornelius;
Sander, Martin;
Gilbert, Sandra;
Czubayko, Frank;
Aigner, Achim

Publication type:

Article

Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu<sup>+</sup> tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 2, p. 219, doi. 10.1007/s00280-008-0729-3

By:

Hardee, Matthew E.;
Eapen, Rose J.;
Rabbani, Zahid N.;
Dreher, Matthew R.;
Marks, Jeffrey;
Blackwell, Kimberly L.;
Dewhirst, Mark W.

Publication type:

Article

In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer.

Published in:

Amino Acids, 2012, v. 42, n. 4, p. 1349, doi. 10.1007/s00726-010-0830-x

By:

Baloria, Urvashi;
Akhoon, Bashir;
Gupta, Shishir;
Sharma, Sujata;
Verma, Vijeshwar

Publication type:

Article

Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 160, doi. 10.1159/000333396

By:

Huober, Jens;
Baumann, Michael;
Rochlitz, Christoph;
Aebi, Stefan;
Güth, Uwe;
von Moos, Roger;
Müller, Andreas;
von Rohr, Lukas;
Widmer, Isabelle;
Thürlimann, Beat

Publication type:

Article

Perspectives on Anti-HER Monoclonal Antibodies.

Published in:

Oncology, 2002, v. 63, p. 17, doi. 10.1159/000066203

By:

Ranson, Malcolm;
Sliwkowski, Mark X.

Publication type:

Article

Emerging Technologies for HER2 Testing.

Published in:

Oncology, 2002, v. 63, p. 33, doi. 10.1159/000066199

By:

van de Vijver, Marc

Publication type:

Article

What Can We Learn from Herceptin[sup ®] Trials in Metastatic Breast Cancer?

Published in:

Oncology, 2002, v. 63, p. 39, doi. 10.1159/000066200

By:

Bell, Richard

Publication type:

Article

Moving Forward: Herceptin[sup ®] in the Adjuvant Setting.

Published in:

Oncology, 2002, v. 63, p. 57, doi. 10.1159/000066201

By:

Tan-Chiu, Elizabeth;
Piccart, Martine

Publication type:

Article

Design of Polyepitope DNA Vaccine against Breast Carcinoma Cells and Analysis of Its Expression in Dendritic Cells.

Published in:

Bulletin of Experimental Biology & Medicine, 2016, v. 160, n. 4, p. 486, doi. 10.1007/s10517-016-3203-y

By:

Nazarkina, Zh.;
Khar'kova, M.;
Antonets, D.;
Morozkin, E.;
Bazhan, S.;
Karpenko, L.;
Vlasov, V.;
Ilyichev, A.;
Laktionov, P.

Publication type:

Article

Evaluation and Simulation of Docking Peptide Labeled with Technetium-99m (Tc-99m) with Human Epidermal Growth Factor Receptor 2 (HER2) in HER2-Positive Breast Cancer Cells.

Published in:

Jentashapir Journal of Cellular & Molecular Biology, 2023, v. 14, n. 4, p. 1, doi. 10.5812/jjcmb-139817

By:

Reyhani, Mohammad Mehdi;
Minaeefar, Amir Abbas;
Dadfar, Fereshteh;
Bamdad, Kourosh

Publication type:

Article

DFT Simulation of Berberine Chloride with Spectroscopic Characterization – Biological activity and Molecular Docking against Breast Cancer.

Published in:

Polycyclic Aromatic Compounds, 2024, v. 44, n. 3, p. 1556, doi. 10.1080/10406638.2023.2201457

By:

Zochedh, Azar;
Chandran, Kaliraj;
Priya, Mohana;
Sultan, Asath Bahadur;
Kathiresan, Thandavarayan

Publication type:

Article

Herceptin-conjugated magnetic polystyrene-Agsbox nanoparticles as a theranostic agent for breast cancer.

Published in:

Journal of Biomaterials Applications, 2022, v. 36, n. 9, p. 1599, doi. 10.1177/08853282211065085

By:

Karahaliloğlu, Zeynep;
Kilicay, Ebru;
Hazer, Baki

Publication type:

Article

HER2 genotype and tumor cells proliferation in urinary bladder cancer.

Published in:

Oncolog-Hematolog, 2024, n. 67, p. 49

By:

Dumitru, Mirela;
Mihăilă, Mirela;
Hotnog, Camelia-Mia;
Botezatu, Anca;
Vasilescu, Monica-Maria;
Panait, Marieta-Elena;
Hortopan, Monica;
Anton, Gabriela;
Braşoveanu, Lorelei-Irina

Publication type:

Article

Targeting HER2 beyond breast cancer.

Published in:

Molecular & Cellular Oncology, 2019, v. 6, n. 3, p. N.PAG, doi. 10.1080/23723556.2019.1571984

By:

Bhatnagar, Sanchita;
Tushir-Singh, Jogender

Publication type:

Article

A comparison study of HER2 protein overexpression and its gene status in breast cancer.

Published in:

Malaysian Journal of Pathology, 2019, v. 41, n. 2, p. 133

By:

MD PAUZI, Suria Hayati;
SAARI, Hanis Nabihah;
ROSLAN, Muhammad Ridzuan;
SYED KHAIR AZMAN JAMALULIL, Sharifah Nor Shairah;
TAUAN, Irene Scully;
MOHD RUSLI, Fatin Adiela;
AIZUDDIN, Azimatun Noor

Publication type:

Article

EGF-Induced Activation of the EGF Receptor Does Not Trigger Mobilization of Caveolae.

Published in:

Traffic, 2006, v. 7, n. 11, p. 1518, doi. 10.1111/j.1600-0854.2006.00487.x

By:

Kazazic, Maja;
Roepstorff, Kirstine;
Johannessen, Lene E.;
Pedersen, Nina M.;
van Deurs, Bo;
Stang, Espen;
Madshus, Inger H.

Publication type:

Article

The unique monoclonal antibodies and immunochemical assay for comprehensive determination of the cell-bound and soluble HER2 in different biological samples.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54590-z

By:

Antos, Aleksandra;
Topolska-Woś, Agnieszka;
Woś, Marcin;
Mitura, Agata;
Sarzyńska, Paulina;
Lipiński, Tomasz;
Kurylcio, Andrzej;
Ziółkowski, Piotr;
Świtalska, Marta;
Tkaczuk-Włach, Joanna;
Gamian, Andrzej;
Polkowski, Wojciech P.;
Staniszewska, Magdalena

Publication type:

Article

Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40071-2

By:

Orrù, Sandra;
Pascariello, Emanuele;
Pes, Barbara;
Rallo, Vincenzo;
Barbara, Raffaele;
Muntoni, Marta;
Notari, Francesca;
Fancello, Gianfranco;
Mocci, Cristina;
Muroni, Maria Rosaria;
Cossu-Rocca, Paolo;
Angius, Andrea;
De Miglio, Maria Rosaria

Publication type:

Article

Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37058-4

By:

Dong, Shengli;
Matossian, Margarite D.;
Yousefi, Hassan;
Khosla, Maninder;
Collins-Burow, Bridgette M.;
Burow, Matthew E.;
Alahari, Suresh K.

Publication type:

Article

Discordance of human epidermal growth factor receptor 2‐low status between breast primary and distant metastases with clinical–pathological correlation.

Published in:

Histopathology, 2025, v. 86, n. 3, p. 441, doi. 10.1111/his.15346

By:

Yang, Ellen;
D'Alfonso, Timothy M;
Morrow, Monica;
Brogi, Edi;
Wen, Hannah Y

Publication type:

Article

Refining the definition of HER2‐low class in invasive breast cancer.

Published in:

Histopathology, 2022, v. 81, n. 6, p. 770, doi. 10.1111/his.14780

By:

Atallah, Nehal M;
Toss, Michael S;
Green, Andrew R;
Mongan, Nigel P;
Ball, Graham;
Rakha, Emad A

Publication type:

Article

What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.

Published in:

Histopathology, 2019, v. 74, n. 6, p. 917, doi. 10.1111/his.13812

By:

Koopman, Timco;
Buikema, Henk J;
Hollema, Harry;
Bock, Geertruida H;
Vegt, Bert

Publication type:

Article

Equivocal (HER2 IHC 2+) breast carcinomas: gene–protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits.

Published in:

Histopathology, 2019, v. 74, n. 2, p. 300, doi. 10.1111/his.13733

By:

Pekar, Gyula;
Kasselaki, Ionna;
Pekar‐Lukacs, Agnes;
Dekany, Csaba;
Hellberg, Dan;
Tot, Tibor

Publication type:

Article

Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing.

Published in:

Histopathology, 2018, v. 73, n. 1, p. 81, doi. 10.1111/his.13507

By:

Bulte, Joris P.;
Halilovic, Altuna;
Kalkman, Shona;
van Cleef, Patricia H. J.;
van Diest, Paul J.;
Strobbe, Luc J. A.;
de Wilt, Johannes H. W.;
Bult, Peter

Publication type:

Article

HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.

Published in:

Histopathology, 2018, v. 72, n. 1, p. 227, doi. 10.1111/his.13333

By:

Qaiser, Talha;
Bhalerao, Abhir;
Rajpoot, Nasir;
Huang, Chao-Hui;
Snead, David;
Mukherjee, Abhik;
Ellis, Ian O;
Ilyas, Mohammad;
Reddy PB, Chaitanya;
Munugoti, Sai D;
Tallam, Vamsi;
Pitkäaho, Tomi;
Lehtimäki, Taina;
Naughton, Thomas;
Berseth, Matt;
Pedraza, Aníbal;
Bueno, Gloria;
Mukundan, Ramakrishnan;
Smith, Matthew;
Rodner, Erik

Publication type:

Article

HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks.

Published in:

Histopathology, 2017, v. 71, n. 4, p. 570, doi. 10.1111/his.13257

By:

Xu, Chen;
Liu, Yalan;
Jiang, Dongxian;
Ge, Xiaowen;
Zhang, Ying;
Su, Jieakesu;
Zeng, Haiying;
Huang, Jie;
Ji, Yuan;
Hou, Jun;
Sun, Yihong;
Shen, Kuntang;
Liu, Tianshu;
Hou, Yingyong;
Qin, Jing

Publication type:

Article

Counting invasive breast cancer cells in the HER2 silver in-situ hybridization test: how many cells are enough?

Published in:

Histopathology, 2017, v. 71, n. 2, p. 247, doi. 10.1111/his.13208

By:

Polónia, António;
Eloy, Catarina;
Pinto, João;
Braga, Ana Costa;
Oliveira, Guilherme;
Schmitt, Fernando

Publication type:

Article

HER2 gene copy number and breast cancer-specific survival.

Published in:

Histopathology, 2016, v. 69, n. 5, p. 871, doi. 10.1111/his.13010

By:

Biserni, Giovanni B;
Engstrøm, Monica J;
Bofin, Anna M

Publication type:

Article

Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?

Published in:

Histopathology, 2016, v. 69, n. 1, p. 20, doi. 10.1111/his.12900

By:

Rakha, Emad A;
Pigera, Marian;
Shin, Sandra J;
D'Alfonso, Timothy;
Ellis, Ian O;
Lee, Andrew H S

Publication type:

Article

Biomarker assessment and molecular testing for prognostication in breast cancer.

Published in:

Histopathology, 2016, v. 68, n. 1, p. 70, doi. 10.1111/his.12795

By:

Kos, Zuzana;
Dabbs, David J.

Publication type:

Article

Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.

Published in:

Histopathology, 2015, v. 67, n. 3, p. 279, doi. 10.1111/his.12649

By:

Pinder, Sarah E;
Rakha, Emad A;
Purdie, Colin A;
Bartlett, John M S;
Francis, Adele;
Stein, Robert C;
Thompson, Alastair M;
Shaaban, Abeer M

Publication type:

Article

Thyroid transcription factor-1 and epithelial membrane antigen expression in four cases of subependymal giant cell astrocytoma.

Published in:

Histopathology, 2015, v. 66, n. 7, p. 1035, doi. 10.1111/his.12540

By:

Chatzopoulos, Kyriakos;
Koletsa, Triantafyllia;
Iliadis, Alexandros;
Karkavelas, Georgios;
Kostopoulos, Ioannis

Publication type:

Article

Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1355081

By:

Kejia Zhu;
Yao Chang;
Delong Zhao;
Andong Guo;
Jishuang Cao;
Chenrui Wu;
Yong Guan;
Sentai Ding

Publication type:

Article

Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.

Published in:

Frontiers in Pharmacology, 2016, p. 8, doi. 10.3389/fphar.2016.00327

By:

Kersh, Anna E.;
Sasaki, Maiko;
Pollack, Brian P.;
Cooper, Lee A.;
Kissick, Haydn T.

Publication type:

Article

Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA.

Published in:

Cellular Microbiology, 2009, v. 11, n. 3, p. 488, doi. 10.1111/j.1462-5822.2008.01269.x

By:

Tegtmeyer, Nicole;
Zabler, Dana;
Schmidt, Diana;
Hartig, Roland;
Brandt, Sabine;
Backert, Steffen

Publication type:

Article

The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.

Published in:

Oncogene, 2015, v. 34, n. 9, p. 1105, doi. 10.1038/onc.2014.56

By:

Huang, Z;
Choi, B-K;
Mujoo, K;
Fan, X;
Fa, M;
Mukherjee, S;
Owiti, N;
Zhang, N;
An, Z

Publication type:

Article

Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 1, p. 133, doi. 10.4143/crt.2014.262

By:

Siew Kuan Lim;
Moo Hyun Lee;
In Hae Park;
Ji Young You;
Byung-Ho Nam;
Byeong Nam Kim;
Jungsil Ro;
Keun Seok Lee;
So-Youn Jung;
Young Mee Kwon;
Eun Sook Lee

Publication type:

Article

Antitumor Activity of HM781-36B, Alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 1, p. 355, doi. 10.4143/crt.2014.260

By:

Mi Hyun Kang;
Sung Ung Moon;
Ji Hea Sung;
Jin Won Kim;
Keun Wook Lee;
Hye Seung Lee;
Jong Seok Lee;
Jee Hyun Kim

Publication type:

Article

Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.

Published in:

Cellular Oncology (2211-3428), 2019, v. 42, n. 1, p. 1, doi. 10.1007/s13402-018-0412-6

By:

Pecero, Mª Luisa;
Salvador-Bofill, Javier;
Molina-Pinelo, Sonia

Publication type:

Article

S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.

Published in:

Cellular Oncology (2211-3428), 2019, v. 42, n. 1, p. 67, doi. 10.1007/s13402-018-0408-2

By:

Kikuchi, Kyoko;
McNamara, Keely May;
Miki, Yasuhiro;
Iwabuchi, Erina;
Kanai, Ayako;
Miyashita, Minoru;
Ishida, Takanori;
Sasano, Hironobu

Publication type:

Article

Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK.

Published in:

Analytical Cellular Pathology: Cellular Oncology, 2011, v. 34, n. 3, p. 101, doi. 10.1155/2011/870459

By:

Villa-Moruzzi, Emma

Publication type:

Article

Deep Learning to Estimate Human Epidermal Growth Factor Receptor 2 Status from Hematoxylin and Eosin-Stained Breast Tissue Images.

Published in:

Journal of Pathology Informatics, 2020, v. 11, p. 1, doi. 10.4103/jpi.jpi_10_20

By:

Anand, Deepak;
Kurian, Nikhil Cherian;
Dhage, Shubham;
Kumar, Neeraj;
Rane, Swapnil;
Gann, Peter H.;
Sethi, Amit

Publication type:

Article

A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence In situ Hybridization Results in Breast Carcinoma.

Published in:

Journal of Pathology Informatics, 2020, v. 11, p. 1, doi. 10.4103/jpi.jpi_52_19

By:

Hartage, Ramon;
Li, Aidan C.;
Hammond, Scott;
Parwani, Anil V.

Publication type:

Article